Key facts
- This page summarizes Thomas A. Mccourt's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2022, 15:01.
Thomas A. Mccourt - 28 Feb 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- IRWD
- Reported as of
- 28 Feb 2022
- Net transaction value
- -$521,526
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2022, 15:01:19 UTC
- Prior SEC filing
- 21 Jan 2022
- Next SEC filing
- 10 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Tessler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas A. Mccourt filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 02 Mar 2022.
Change
- Previous filing in this sequence was filed on 21 Jan 2022.
- Current net transaction value: -$521,526.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRWD
transaction
Class A Common Stock
Sale
- Transaction value
- $20,915
- Shares
- -1,942
- Change %
- -0.31%
- Price
- $10.77
- Shares after
- 632,802
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
IRWD
transaction
Class A Common Stock
Sale
- Transaction value
- $107,980
- Shares
- -10,026
- Change %
- -1.6%
- Price
- $10.77
- Shares after
- 622,776
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
IRWD
transaction
Class A Common Stock
Sale
- Transaction value
- $215,077
- Shares
- -19,970
- Change %
- -3.2%
- Price
- $10.77
- Shares after
- 602,806
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F3
IRWD
transaction
Class A Common Stock
Sale
- Transaction value
- $177,554
- Shares
- -16,486
- Change %
- -2.7%
- Price
- $10.77
- Shares after
- 586,320
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.
Footnote F2
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.
Footnote F3
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting of the reporting person's performance-based restricted stock units granted on February 27, 2020.
Footnote F4
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 22, 2021.